These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 23918220

  • 1. Towards a more desirable dry powder inhaler formulation: large spray-dried mannitol microspheres outperform small microspheres.
    Kaialy W, Hussain T, Alhalaweh A, Nokhodchi A.
    Pharm Res; 2014 Jan; 31(1):60-76. PubMed ID: 23918220
    [Abstract] [Full Text] [Related]

  • 2. Dry powder inhalers: physicochemical and aerosolization properties of several size-fractions of a promising alterative carrier, freeze-dried mannitol.
    Kaialy W, Nokhodchi A.
    Eur J Pharm Sci; 2015 Feb 20; 68():56-67. PubMed ID: 25497318
    [Abstract] [Full Text] [Related]

  • 3. Effect of carrier particle shape on dry powder inhaler performance.
    Kaialy W, Alhalaweh A, Velaga SP, Nokhodchi A.
    Int J Pharm; 2011 Dec 12; 421(1):12-23. PubMed ID: 21945739
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Dry powder inhaler performance of spray dried mannitol with tailored surface morphologies as carrier and salbutamol sulphate.
    Mönckedieck M, Kamplade J, Fakner P, Urbanetz NA, Walzel P, Steckel H, Scherließ R.
    Int J Pharm; 2017 May 30; 524(1-2):351-363. PubMed ID: 28347847
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Aerosolization characteristics of dry powder inhaler formulations for the excipient enhanced growth (EEG) application: effect of spray drying process conditions on aerosol performance.
    Son YJ, Worth Longest P, Hindle M.
    Int J Pharm; 2013 Feb 25; 443(1-2):137-45. PubMed ID: 23313343
    [Abstract] [Full Text] [Related]

  • 9. Development of drug alone and carrier-based GLP-1 dry powder inhaler formulations.
    Babenko M, Alany RG, Calabrese G, Kaialy W, ElShaer A.
    Int J Pharm; 2022 Apr 05; 617():121601. PubMed ID: 35181460
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Dry powder inhalers: mechanistic evaluation of lactose formulations containing salbutamol sulphate.
    Kaialy W, Ticehurst M, Nokhodchi A.
    Int J Pharm; 2012 Feb 28; 423(2):184-94. PubMed ID: 22197772
    [Abstract] [Full Text] [Related]

  • 12. Effect of Roughness on the Dispersion of Dry Powders for Inhalation: a Dynamic Visualization Perspective.
    Kou X, Heng PWS, Chan LW, Wereley ST, Carvajal MT.
    AAPS PharmSciTech; 2019 Jul 30; 20(7):271. PubMed ID: 31363868
    [Abstract] [Full Text] [Related]

  • 13. Effects of formulation and operating variables on zanamivir dry powder inhalation characteristics and aerosolization performance.
    Yang Y, Yang Z, Ren Y, Mei X.
    Drug Deliv; 2014 Sep 30; 21(6):480-6. PubMed ID: 24491208
    [Abstract] [Full Text] [Related]

  • 14. Comparison of the cohesion-adhesion balance approach to colloidal probe atomic force microscopy and the measurement of Hansen partial solubility parameters by inverse gas chromatography for the prediction of dry powder inhalation performance.
    Jones MD, Buckton G.
    Int J Pharm; 2016 Jul 25; 509(1-2):419-430. PubMed ID: 27265314
    [Abstract] [Full Text] [Related]

  • 15. Co-spraying of carriers (mannitol-lactose) as a method to improve aerosolization performance of salbutamol sulfate dry powder inhaler.
    Ferdynand MS, Nokhodchi A.
    Drug Deliv Transl Res; 2020 Oct 25; 10(5):1418-1427. PubMed ID: 31933129
    [Abstract] [Full Text] [Related]

  • 16. Assessment of Dry Powder Inhaler Carrier Targeted Design: A Comparative Case Study of Diverse Anomeric Compositions and Physical Properties of Lactose.
    Pinto JT, Zellnitz S, Guidi T, Roblegg E, Paudel A.
    Mol Pharm; 2018 Jul 02; 15(7):2827-2839. PubMed ID: 29856921
    [Abstract] [Full Text] [Related]

  • 17. The effects of loaded carrier mass and formulation mass on aerosolization efficiency in dry powder inhaler devices.
    Ooi J, Gill C, Young PM, Traini D.
    Curr Drug Deliv; 2015 Jul 02; 12(1):40-6. PubMed ID: 25146438
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of granulated lactose as a carrier for DPI formulations 1: effect of granule size.
    Du P, Du J, Smyth HD.
    AAPS PharmSciTech; 2014 Dec 02; 15(6):1417-28. PubMed ID: 24962007
    [Abstract] [Full Text] [Related]

  • 19. Effect of carrier morphology and surface characteristics on the development of respirable PLGA microcapsules for sustained-release pulmonary delivery of insulin.
    Hamishehkar H, Emami J, Najafabadi AR, Gilani K, Minaiyan M, Mahdavi H, Nokhodchi A.
    Int J Pharm; 2010 Apr 15; 389(1-2):74-85. PubMed ID: 20085803
    [Abstract] [Full Text] [Related]

  • 20. The influence of physical properties and morphology of crystallised lactose on delivery of salbutamol sulphate from dry powder inhalers.
    Kaialy W, Martin GP, Larhrib H, Ticehurst MD, Kolosionek E, Nokhodchi A.
    Colloids Surf B Biointerfaces; 2012 Jan 01; 89():29-39. PubMed ID: 21962946
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.